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Abstract 
The contribution of slow brain oscillations including delta, theta, alpha and sigma frequencies 
(0.5-16 Hz) to the sleep EEG is finely regulated by circadian and homeostatic influences, and reflects 
functional aspects of wakefulness and sleep. Accumulating evidence demonstrates that individual sleep 
EEG patterns in non-rapid-eye-movement (NREM) sleep and rapid-eye-movement (REM) sleep are 
heritable traits. More specifically, multiple recordings in the same individuals, as well as studies in 
monozygotic and dizyogotic twins suggest that a very high percentage of the robust inter-individual 
variation and the high intra-individual stability of sleep EEG profiles can be explained by genetic factors 
(> 90 % in distinct frequency bands). Still little is known about which genes contribute to different sleep 
EEG phenotypes in healthy humans. The genetic variations that have been identified to date include 
functional polymorphisms of the clock gene PER3, and of genes contributing to signal transduction 
pathways involving adenosine (ADA, ADORA2A), brain-derived neurotrophic factor (BDNF), 
dopamine (COMT), and prion protein (PRNP). Some of these polymorphisms profoundly modulate 
sleep EEG profiles; their effects are reviewed here. It is concluded that the search for genetic 
contributions to slow sleep EEG oscillations constitutes a promising avenue to identify molecular 
mechanisms underlying sleep-wake regulation in humans. 
Hans-Peter Landolt Genetic aspects of human sleep EEG 
 3 
Introduction 
The presence or absence of slow brain oscillations in the EEG, together with information 
obtained from an electrooculogram (EOG) and an electromyogram (EMG), underlies the polygraphic 
discrimination among the three basic vigilance/sleep states wakefulness, non-rapid-eye-movement 
(NREM) sleep and rapid-eye-movement (REM) sleep (Iber et al., 2007). A powerful tool to quantify 
amplitude and prevalence of EEG oscillations with distinct frequencies is power spectral analysis 
based on the Fast-Fourier Transform (FFT) (Borbély et al., 1981). This method faithfully reveals the 
EEG characteristics of wakefulness, NREM sleep, and REM sleep. Rested wakefulness with closed 
eyes is characterized in many individuals by regular alpha (~ 9-12 Hz) activity. Decreasing alpha 
activity and increasing prevalence of theta (~ 5-9 Hz) oscillations, together with slow eye movements, 
herald the transition into NREM sleep (stage N1). The EEG in more superficial sleep (stage N2) is 
characterized by phasic events representing sleep spindles (~ 12-16 Hz, sigma frequency range) and 
K-complexes. In deep slow wave sleep (stage N3), high-amplitude, slow waves in the low delta 
frequency range (0.5-2 Hz) are most prevalent. The amplitude and prevalence of delta oscillations are 
highest shortly after sleep onset and decrease during sleep, in parallel with decreasing sleep depth. 
The decline of EEG delta activity during NREM sleep is not monotonous, but is interrupted by the 
periodic occurrence of REM sleep (stage R). This state is identified by low-amplitude EEG activity 
characterized by theta and higher frequency oscillations, rapid eye movements, and atonia in 
antigravity muscles. 
 
Sleep-wake regulation 
Salient features of nocturnal sleep in humans include a declining trend in EEG delta/theta 
activity, an increase in the frequency range of sleep spindles, and a decrease in the ratio between 
NREM sleep and REM sleep in the course of the night. These characteristics reflect the influence of 3 
basic processes assumed to underlie physiological sleep-wake regulation (Borbély and Achermann, 
2005). (1) A circadian process as the output of an oscillator with an endogenous period of roughly to 
24 hours (lat. “circadian” = approximately one day) that determines the daily phases of high and low 
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propensity for sleep, REM sleep and wakefulness. (2) A homeostatic process keeping track of ‘sleep 
propensity’ or ‘sleep need’, which accumulates during wakefulness and dissipates during sleep. And 
(3), an ultradian process underlying the cyclic occurrence of NREM and REM sleep across the sleep 
episode. 
According to the Two-Process Model of sleep regulation (Borbély, 1982), the interaction 
between the sleep-wake independent, circadian Process C and the sleep-wake dependent, homeostatic 
Process S regulates variations in sleep propensity, the alternation between waking and sleep episodes, 
NREM sleep structure and intensity, and the timing of REM sleep. Thus, sleep is an active process, 
which is finely and reliably regulated. Recovery sleep after sleep deprivation occurs with reduced 
latency, and is prolonged and more intense than baseline sleep. The duration of slow wave sleep and 
initial low-frequency (delta/theta) activity rise as a function of time awake, while spindle frequency 
activity is typically reduced after sleep loss (Borbély and Achermann, 2005; Borbély et al., 1981). 
Taken together, the EEG in NREM sleep undergoes highly predictable changes reflecting 
physiological sleep-wake regulation. Nevertheless, abundant evidence exists that also strong genetic 
influences contribute to major characteristics of sleep and the sleep EEG, as well as of the waking 
EEG. 
 
Heritability of waking EEG 
Classic twin studies have long suggested that additive genetic factors (referred to as 
heritability) clearly outweigh the environmental influences on the waking EEG. More specifically, 
EEG profiles show much higher resemblance between monozygotic twins than between dizygotic 
twins and unrelated persons (Lennox et al., 1945; Vogel, 1958). Later studies revealed high test-retest 
correlations in spontaneous waking EEG activity and confirmed that genetic influences importantly 
contribute to the pronounced inter-individual differences observed in the waking EEG (Stassen et al., 
1987; van Beijsterveldt et al., 1996). Boomsma and co-workers estimated that delta (1.5-3.5 Hz), theta 
(4.0-7.5 Hz), alpha (8.0-12.5 Hz) and beta (13.0-25.0 Hz) frequencies show heritabilities of 76 %, 
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89 %, 89 % and 86 %, respectively (van Beijsterveldt et al., 1996). Similarly, the heritability of the 
peak frequency in the alpha range equals roughly 80 % (van Beijsterveldt and van Baal, 2002). 
Bodenmann et al. (2009a) recently reported that the functional Val158Met polymorphism of the gene 
encoding catechol-O-methyltransferase (COMT) predicts a difference of 1.4 Hz in alpha peak 
frequency between homozygous Val and Met allele carriers of COMT.  
 
Trait-like nature of sleep and sleep EEG characteristics 
Sleep architecture 
Not only the waking EEG, but also self-reported and polysomnographically recorded sleep 
characteristics such as inter-individual variation in diurnal preference, sleep duration, sleep structure, 
and the EEG in NREM sleep and REM sleep have all been shown to be under strong genetic control 
(Landolt and Dijk, 2010). Already the first sleep studies in monozygotic twins revealed almost 
complete concordance in the temporal sequence of sleep stages (Zung and Wilson, 1966). Later work 
demonstrated that in particular those sleep variables that most reliably reflect homeostatically 
regulated sleep propensity are under tight genetic control. Apart from total sleep time, they include the 
duration of NREM sleep stages, especially slow wave sleep, and the density of rapid eye movements 
in REM sleep. Linkowski (1999) estimated that rapid-eye-movement-density shows heritability of 
95 %. 
To quantify the stability, robustness and magnitude of inter-individual variation in sleep 
variables, Tucker et al. (2007) completed in 21 young adults 8 all-night polysomnographic recordings 
interspersed with three 36-hour periods of extended wakefulness. They found that almost all sleep 
variables that define sleep structure exhibit stable and robust – i.e., trait-like – inter-individual 
differences characterized by intra-class correlation coefficients (ICC) of 36-89 %. The ICC estimates 
the intra-individual stability of a variable across different conditions (e.g., baseline sleep vs. recovery 
sleep after prolonged wakefulness) and equals for slow wave sleep 73 %. This high value reflects 
substantial stability across equivalent nights (baseline and recovery nights) and substantial robustness 
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against external influences such as sleep deprivation (Tucker et al., 2007). Not only for slow wave 
sleep, but also for stage 2 (N2) and REM sleep, the robust inter- individual differences are 
considerably larger in magnitude than the effect of prolonged wakefulness. 
 
The EEG in NREM sleep and REM sleep 
Due to the prevalence of slow waves, the EEG in NREM sleep is characterized by highest 
power in the delta range and decreasing activity with increasing frequencies. Reflecting sleep 
spindles, a secondary prominent peak in the power spectrum is also present in the 11-16 Hz range. 
Even in a homogenous sample of young men adhering to stringently controlled sleep-wake patterns 
prior to laboratory sleep recordings (Bodenmann et al., 2009a), the EEG in NREM sleep shows 
pronounced inter-individual variation (Fig. 1A). To investigate whether such differences are stable 
and reflect individual traits, inter-individual variation and intra-individual stability in sleep and the 
sleep EEG characteristics were studied in 8 male volunteers across 4 separate recordings (2 pairs of 
baseline nights 4 weeks apart) (Buckelmüller et al., 2006). It was found that the EEG in NREM sleep, 
but also in REM sleep, differed largely among all individuals. The absolute power values and the 
shape of each subject’s spectra, however, are impressively constant. Hierarchical cluster analyses of 
Euclidean distances based on feature vectors of EEG spectral values demonstrated that all nights of 
each individual segregated into the same single cluster (Buckelmüller et al., 2006). In other words, 
each participant of that study could be separated from the other members of the sample, only based on 
the EEG power spectra in NREM sleep and REM sleep. The distribution of similarity coefficients of 
EEG feature vectors confirmed high between-subject variation and high within-subject stability. This 
was true, even when the EEG in NREM sleep was separately analyzed for the first and second halves 
of the nights. Thus, within-subject stability of the NREM sleep EEG is independent of homeostatic 
sleep pressure. By contrast, within-subject similarity between the first and second halves of each night 
is as low as between-subject similarity. This finding reflects the systematic EEG changes in NREM 
sleep associated with the dissipation of sleep propensity in the course of the night. 
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Another research group used an alternative approach, to examine the inter-night reliability in 
quantitative sleep EEG measures. Firstly, Tan et al. (2000) reported remarkably high Pearson 
correlation coefficients (r ≈ 0.9) in delta (0.3-3 Hz), sigma (12-15 Hz), and beta (15-23 Hz) 
frequencies in NREM sleep in 16 young adults (10 men, 6 women; age range: 19-26 years) who 
underwent five consecutive baseline night recordings. Because this high inter-night reliability was not 
dependent on EEG amplitude, which could reflect unspecific or extra-cerebral factors such as scull 
thickness, it was concluded that electrical brain activity in NREM sleep is reliable. To corroborate this 
conclusion, the same authors conducted a second study of 4 non-consecutive nights in 19 young (10 
men, 9 women; age range: 20-25 years) and 19 elderly (8 men, 11 women; age range: 65-82 years) 
volunteers. They extended their analyses to 26 distinct frequency bands in NREM and REM sleep and 
found that the spectral values in both age groups differ significantly among individuals, yet are highly 
consistent within subjects. The inter-night reliability coefficients (r) equal between 0.8 and 0.95 for all 
frequency bands. Notably, the sleep EEG spectra in the elderly appeared to be as highly reliable as 
those in the young adults. 
Taken together, accumulating data strongly suggest that individual EEG profiles in NREM 
and REM sleep are genetically determined. 
 
Heritability of sleep EEG 
This notion is further supported by the recent publication of two twin studies of the sleep 
EEG. Ambrosius et al. (2008) quantified the EEG profiles in NREM sleep in 35 pairs of monozygotic 
twins (17 male pairs, 18 female pairs; age range: 17-43 years) and 14 pairs of dizygotic twins  (7 male 
pairs, 7 female pairs; age range: 18-26 years). Genetic variance analysis identified substantial genetic 
influences on spectral power in 2-13 Hz oscillations. The ICC reflecting within-pair similarity is 
higher in monozygotic twins (ICC ≈ 0.8) than in dizygotic twins (ICC ≈ 0.6). The differences between 
monozygotic and dizygotic twins include the EEG frequency bands capturing delta waves (0.75-
4.5 Hz) and sleep spindles (12-13.75 Hz), yet appear most pronounced in theta and alpha (4.75-
11.75 Hz) frequencies (Fig. 1B). 
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De Gennaro and colleagues (2008) tested the hypothesis that the EEG in NREM sleep 
provides an individual “fingerprint”, which is genetically determined.  They recorded baseline and 
recovery sleep after sleep deprivation in 40 healthy subjects (mean age: 24.6 ± 2.4 years), consisting 
of 10 pairs of monozygotic (5 male pairs, 5 female pairs) and 10 pairs of dizygotic  (5 male pairs, 5 
female pairs) twins. They observed highest variability in the 8-16 Hz range and restricted their 
analyses to this frequency band. Group similarity as quantified by an ICC procedure is consistently 
higher in monozygotic twin pairs (ICC = 0.934; 95 % confidence intervals: 0.911-0.965) than in 
dizygotic twin pairs (ICC = 0.459; 95 % confidence intervals: 0.371-0.546). In fact, the similarity 
values in the monozygotic twins are comparable to the mean correlation coefficient (r = 0.958 ± 
0.026) in this frequency range across six different experimental nights of single individuals (De 
Gennaro et al., 2005). The authors estimated that the heritability of the 8-16 Hz range in NREM sleep 
is as high as 95.9 % and independent of sleep propensity (De Gennaro et al., 2008). This finding 
suggests that the sleep EEG qualifies as the most heritable trait known so far, matched only by 
heritabilities for brain architecture such as the distribution of grey matter in the cerebral cortex 
(Andretic et al., 2008). Considering the facts that functional brain connectivity and rhythmic brain 
oscillations are determined by common genetic factors (Posthuma et al., 2005) and that the frequency-
specific, regional distribution of EEG power in NREM sleep is highly stable (De Gennaro et al., 2005; 
Finelli et al., 2001), it is possible that these two traits are inter-related. 
In conclusion, strong evidence suggests that the sleep EEG is a highly heritable trait. 
Nevertheless, the underlying genetic determinants are largely unknown. Only a few studies are 
currently available in humans, which investigated the effects of known allelic variants of candidate 
genes on the sleep EEG. Nevertheless, the findings demonstrate that single genes can profoundly 
modulate sleep and sleep EEG phenotypes. The findings are summarized in Table 1 and will be 
briefly discussed in the following paragraphs. 
 
Genetic polymorphisms affecting sleep and sleep EEG 
Variable-number-tandem-repeat polymorphism of PERIOD3 (PER3) gene 
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A 54-nucleotide sequence in the coding region of the clock gene PERIOD3 (PER3) located 
on human chromosome 1 is either repeated in four or five units (SNP-ID number: rs57875989). The 
repeated segments are translated into numerous potential phosphorylation sites and may alter post-
translational modification and stability of PER3 protein (Dijk and Archer, 2010). Viola et al. (2007) 
observed that homozygous carriers of the long-repeat genotype (6 men, 4 women; mean age: 25.2 
years) fall asleep more rapidly and showed more slow wave sleep than homozygous 4-repeat 
individuals (8 men, 6 women; mean age: 24.8 years). In addition, in recovery sleep after sleep 
deprivation, REM sleep is reduced in PER3
5/5
 individuals compared to PER3
4/4
 homozygotes. 
Not only sleep architecture, but sleep EEG profiles are affected by this polymorphism. More 
specifically, the carriers of the PER3
5/5
 genotype have higher EEG activity in the delta range (1-2 Hz) 
in NREM sleep and in the theta/alpha range (7-10 Hz) in REM sleep when compared to the the 
PER3
4/4
 genotype (Viola et al., 2007). Moreover, the findings of another group suggested that the 
increase in slow-wave energy after acute sleep restriction is slightly elevated in adults carrying the 
PER3
5/5
 (n = 14) genotype when compared to PER3
4/5
 (n = 63) and PER3
4/4
 (n = 52) allele carriers 
(aged 22-45 years) (Goel et al., 2009). Slow-wave energy refers to EEG power within 0.5-4.5 Hz 
accumulated over all epochs of stage 2-4 sleep in the first two NREM sleep episodes. 
 
22G>A polymorphism of adenosine deaminase (ADA) gene 
Convergent pharmacologic and genetic evidence strongly suggests that the adenosine 
neuromodulator/neurotransmitter system is importantly involved in the homeostatic regulation of 
sleep (Landolt, 2008). The enzyme adenosine deaminase (ADA) catalyzes the irreversible degradation 
of adenosine to inosine and contributes to the regulation of extracellular adenosine levels. The human 
ADA gene is located on chromosome 20q13.11 and encodes two electrophoretic variants of ADA, 
referred to as ADA*1 and ADA*2 (SNP-ID number: rs73598374). The ADA*2 variant results from a 
guanine-to-adenine transition at nucleotide 22, which is translated into a asparagine-to-aspartic acid 
substitution at codon 8. The heterozygous ADA*1-2 (G/A) genotype shows reduced catalytic activity 
of ADA compared to homozygous individuals carrying the ADA*1 (G/G genotype) variant {Riksen, 
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2008 #6948}.  Rétey et al. {, 2005 #6495} found that healthy adults with the G/A genotype  (5 men, 2 
women; mean age: 26.4 years) have roughly 30 min more slow wave sleep in an 8-hour baseline sleep 
episode than individually-matched subjects with the G/G genotype (5 men, 2 women; mean age: 26.1 
years). This difference is similar in magnitude to the effect on recovery sleep of one night of total 
sleep deprivation. All other sleep variables are comparable in both genotypes. 
The 22G>A polymorphism of ADA also affects the spectral composition of the sleep EEG. 
Thus, EEG activity is higher within the delta range in the G/A genotype compared to the G/G 
genotype in NREM sleep (0.25-5.5 Hz), as well as in REM sleep (2.0-2.25 and 3.5-4.75 Hz) (Rétey et 
al., 2005). Consistent with these findings in humans, genetic studies in inbred mice revealed that a 
genomic region including Ada modifies the rate, at which NREM sleep need accumulates during 
wakefulness (Franken et al., 2001). Moreover, local pharmacological inhibition of ADA in rats 
increases extracellular adenosine concentration and the duration of deep NREM sleep (Okada et al., 
2003). Bachmann et al. (manuscript under review) investigated whether G/A and G/G genotypes of 
ADA respond differently to prolonged wakefulness. Consistent with the previous data, these 
researchers found that slow wave sleep and low-frequency delta (0.75-1.5 Hz) activity in NREM sleep 
are elevated in G/A compared to G/G genotype. The difference is invariably present in baseline and 
recovery nights. In addition, ADA genotype-dependent alterations in the EEG profile are not restricted 
to the low-delta range in NREM sleep, but also include a pronounced increase theta/alpha frequencies 
(~ 6-12 Hz) in NREM sleep, REM sleep, and wakefulness.  
 
1976T>C polymorphism of adenosine A2A receptor (ADORA2A) gene 
The cellular effects of adenosine are mediated via four different subtypes of G-protein-
coupled adenosine receptors: A1, A2A, A2B, and A3 receptors. For the effects on sleep and the sleep 
EEG, however, the A1 and A2A receptors may be primarily important (Landolt, 2008). A common 
synonymous 1976T>C variation (SNP-ID number: rs5751876) on chromosome 22q11.2 is located in 
the coding region of the adenosine A2A receptor gene (ADORA2A). This polymorphism is linked to a 
2592C>Tins polymorphism in the 3’-UTR of ADORA2A, and may modulate receptor protein 
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expression (Alsene et al., 2003). Rétey and co-workers observed that the 1976T>C polymorphism not 
only contributes to individual sensitivity to the effects of caffeine on sleep  (Rétey et al., 2007), but 
also affects EEG activity in all sleep/vigilance states. In a case-control study, spectral power in the 
~ 7-10 Hz range was shown to be invariably higher in subjects with the C/C genotype than in subjects 
with the T/T genotype (Rétey et al., 2005). Because the C allele of ADORA2A is thought to facilitate 
A2A receptor function when compared to the T allele, these data may suggest that genetically 
increased A2A receptor-mediated signal transduction enhances EEG theta/alpha activity in 
vigilance/sleep state-unspecific manner.  
 
196G>A polymorphism of brain-derived neurotrophic factor (BDNF) gene 
Another region in the mouse genome affecting the accumulation of sleep propensity during 
wakefulness includes the gene encoding the neurotrophic receptor, tyrosine kinase B (TrkB) (Franken 
et al., 2001). This genetic locus explains almost 50 % of the variance in the rebound in delta activity 
after sleep deprivation. It may, thus, contain a major gene contributing to sleep-wake regulation. TrkB 
is the high-affinity receptor for brain-derived neurotrophic factor (BDNF) (Luikart and Parada, 2006), 
and recent findings in rats suggest that BDNF secretion is causally related to sleep homeostasis 
(Faraguna et al., 2008; Huber et al., 2007). 
In humans, BDNF is expressed throughout the brain, particularly in prefrontal cortex and 
hippocampus (Pezawas et al., 2004). This neurotrophin exerts long-term effects on neuronal survival, 
migration, and dendritic/axonal growth. The BDNF gene is located on chromosome 11p13 and 
composed of five or more exons. One functional polymorphism of this gene appears to occur with 
high frequency in humans (SNP-ID number: rs6265). Specifically, a guanine-to-adenine transition at 
nucleotide 196 produces a valine-to-methionine amino acid substitution at codon 66 of the pro-BDNF 
sequence. In vitro studies suggest that the Met allele impacts activity-dependent secretion and 
intracellular trafficking of BDNF (Egan et al., 2003). Furthermore, neuropsychological testing 
revealed that this polymorphism is typically associated with reduced performance on tasks, which are 
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also impaired by sleep deprivation, including various types of memory, fine motor tasks and executive 
functions (Egan et al., 2003; Pezawas et al., 2004). 
To investigate whether the Val66Met polymorphism of BDNF affects the sleep EEG, 11 
carriers of the variant allele (Val/Met genotype; 4 women, 7 men; 20-29 years) were prospectively 
matched on an individual basis with 11 Val/Val homozygotes (4 women, 7 men; 20-29 years). Sleep 
and sleep EEG were studied in baseline and recovery nights after 40 hours prolonged wakefulness. In 
baseline and recovery conditions, slow wave sleep is shorter in Val/Met than in Val/Val genotype 
(Bachmann et al., manuscript under review). Moreover, in both nights, EEG activity is lower in Met 
allele carriers than in Val/Val homozygotes, particularly in delta (baseline: 1.5-3 Hz; recovery: 0-0.75 
& 2-2.75 Hz) and theta (baseline: 6-8.25 Hz; recovery: 5.75-8 Hz) frequencies in NREM sleep. In 
contrast to the to previously discussed ADA and ADORA2A polymorphisms, the BDNF genotype-
dependent differences in the theta range are NREM sleep-specific and not present in REM sleep and 
wakefulness. This finding indicates that genetic variation of adenosine and BDNF affect theta activity 
via different underlying mechanisms. 
 
544G>A polymorphism of catechol-O-methyltransferase (COMT) gene 
The gene encoding COMT is located on human chromosome 22q11.2, and contains a 
common functional 544G>A variation altering the amino acid sequence of COMT protein at codon 
158 from Val to Met (SNP-ID number: rs4680). Individuals homozygous for the Val allele show 
higher COMT activity and lower dopaminergic signaling in prefrontal cortex than Met/Met 
homozygotes (Akil et al., 2003). Sleep variables and the sleep EEG response to sleep deprivation do 
not differ between male carriers of Val/Val and Met/Met genotypes (Bodenmann and Landolt, 2010). 
By contrast, the variation of the COMT gene is associated with consistently lower EEG activity in the 
upper alpha (11-13 Hz) range in NREM sleep, REM sleep, and wakefulness (Bodenmann et al., 
2009a). The difference in NREM sleep (Fig. 2) is present before and after sleep deprivation, and 
altered by administration of a moderate dose of the stimulant modafinil during prolonged 
wakefulness. By contrast, the polymorphism, however, profoundly modulates the efficacy of 
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modafinil to improve impaired well-being and cognitive functions after sleep deprivation 
(Bodenmann et al., 2009b).  
 
385A>G polymorphism of prion protein (PRNP) gene 
A point mutation at codon 178 (in rare cases also a mutation at codon 200) of the prion 
protein gene (PRNP) causes fatal familial insomnia (FFI) (Lugaresi et al., 1986). Healthy relatives of 
FFI patients appear to have normal sleep EEG (Ferrillo et al., 2001). By contrast, the polymorphic 
codon 129 of the PRNP gene (SNP-ID number: rs1799990) may influence EEG activity in NREM 
sleep (Plazzi et al., 2002). A preliminary analysis indicated that subjects with Met/Val genotype have 
lower slow-wave activity and higher spindle frequency activity than individuals with the Val/Val 
genotype. 
 
Concluding remarks 
Polymorphic variations in a number of genes (PER3, ADA, ADORA2A, BDNF, COMT, 
PRNP) have now been shown to affect distinct characteristics of sleep and sleep EEG in humans. 
Consistent with recent findings showing that EEG differences in NREM sleep between monozygotic 
and dizygotic twin pairs are independent of elevated sleep propensity, profound genotype-dependent 
differences are mostly present in baseline and persist in recovery sleep after sleep deprivation (Table 
1). The consistent effects, particularly in the theta/alpha range, of these genes in NREM sleep, REM 
sleep and wakefulness support the hypothesis that common neuronal mechanisms underlie the 
generation of major EEG oscillations. On the other hand, functional polymorphisms of PER3, ADA 
and BDNF cause state- and frequency-specific differences within the slow-wave range (~ 0.5-3 Hz) in 
NREM sleep. These genes may contribute to the regulation of sleep homeostasis. Elucidating the 
signaling pathways that are affected by these genetic variations will aid our understanding of 
molecular mechanisms underlying sleep, and may provide new targets for the pharmacological 
improvement of disturbed sleep in humans. 
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Table 1. Genes contributing in healthy adults to genotype-dependent differences in NREM and REM sleep EEG profiles. 
Gene 
NCBI SNP-ID 
(major/minor alleles) 
Amino acid 
substitution 
NREM sleep REM sleep Frequency 
range Baseline Recovery Baseline Recovery 
PER3 rs57875989 
del(3031-3084 nt) 
del(1011-1028 aa) 1.0-2.0 Hz   
7.0-10.0 Hz 
 Delta 
Theta 
ADA rs73598374 
(G/A) 
Asp8Asn 0.25-5.5 Hz 
 
0.5-1.25 Hz 
6.75-10.0 Hz 
 
 
1.0-1.25 Hz 
7.75-10.0 Hz 
2.0-2.25 Hz, 
3.5-4.75 Hz 
 
 
 
7.75-8.0 Hz 
Delta 
 
 
Theta 
ADORA2A rs5751876 
(T/C) 
n/a 7.25-9.0 Hz  6.5-9.25 Hz  Theta 
BDNF rs6265 
(G/A) 
Val66Met 1.5-3.0 Hz 
 
6.0-8.25 Hz 
0-0.75 Hz, 
2.0-2.75 Hz 
5.75-8.0 Hz 
12.5-13.0 Hz 
 
 
8.25-8.75 Hz 
0.5-0.75 Hz 
 
 
16.25-16.5 Hz 
Delta 
 
Theta 
Sigma 
COMT rs4680 
(G/A) 
Val158Met 10.25-12.0 Hz  10.5-14.0 Hz  Alpha 
PRNP rs1799990 
(A/G) 
Met129Val 0.5-4.0 Hz 
12.5-16.0 Hz 
   Delta 
Sigma 
Gene: National Center for Biotechnology Information (NCBI) gene symbol. NCBI SNP-ID number: Single nucleotide polymorphism reference number. n/a: No 
amino acid substitution (silent polymorphism). Frequency bands within delta (< 5 Hz), theta (~ 5-9 Hz), alpha (~ 9-12 Hz) and sigma (~ 12-16 Hz) ranges refer to 
significant differences between genotypes in baseline and/or recovery nights after sleep deprivation. Note the virtual independence from elevated sleep propensity 
of the genotype-dependent differences in NREM sleep. 
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Legends to the Figures 
Figure 1. Healthy adults have highly variable sleep EEG profiles that are genetically determined. (A) 
All-night EEG power spectra in NREM sleep (stages 1-4) in 22 male volunteers (23.4±0.5 years) in 
baseline (mean of two baseline sleep recordings). Data from Bodenmann et al. (2009a). (B) Group 
differences in within-pair similarity as quantified by intra-class correlation coefficients (ICC) in 
distinct EEG frequency bands between monozygotic (black bars) and dizygotic (white bars) twin 
pairs. Thirthy-five pairs of monozygotic twins (17 male pairs, 18 female pairs) and 14 pairs of 
dizygotic twins  (7 male pairs, 7 female pairs). The ICC values were re-plotted from published data 
(Ambrosius et al., 2008). 
Figure 2. The 544G>A (Val158Met) polymorphism of COMT modulates EEG alpha activity in 
NREM sleep (all-night power spectra of stages 1-4). Black bars at the bottom of the panels indicate 
frequency bins, which differed significantly between Val/Val (n = 10, black lines) and Met/Met (n = 
12, grey lines) genotypes (p < 0.05, unpaired, two-tailed t-tests). The two baseline nights were 
recorded one week apart. Data from Bodenmann et al. (2009a). 
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